A Study to Evaluate the Efficacy and Safety of BIIB131 for Participants With Ischemic Stroke Between 4.5 and 24 Hours After Last Known Well

Clinical trial NCT05764122 · WITHDRAWN

Trial details

NCT number: NCT05764122
Sponsor: Biogen
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Ischemic Stroke

Start date: 2024-03-29
Primary completion: 2025-07-07
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.